Results

Search Product

Structure Search

Search

Online Support

Customer service

Advantage Products

Adefovir Dipivoxil Intermediates

2-Aminothiazole

Di-p-xylylene

5-Bromo-4-chloro-3-indolyl phosphate p-toluidine salt

N-Cyclohexyl-3-aminopropanesulfonic acid

(±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid

Nitrotetrazolium blue chloride

3-(2-Spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)phenyl-1,2-dioxetane

N-[2-(diethylamino)ethyl]acrylamide

POLYQUATERNIUM-1

4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid(HEPES)

Tris

3,3',5,5'-Tetramethylbenzidine

Trometamol

Trometamol

4-BROMO-2-THIOPHENECARBOXALDEHYDE

Guanidine hydrochloride

IPTG

Guanidine isothiocyanate

Location: Results

拜耳的新型注射器被FDA批准
2015-09-29
多发性硬化症新药ocrelizumab三期研究效果出众
2015-09-23
cladribine再一次敲击FDA和EMA的大门
2015-09-14
YACOO：赛诺菲多发性硬化症新药Lemtrada获FDA批准上市
2014-11-18
YACOO:进展型多发性硬化症药物研究：2019年或将有新药完成
2014-10-23
2023年全球多发性硬化症（MS）市场将达200亿美元
2014-08-13
6 items in total,current page 1/1,10 items per page

first 1 last turn to go

Copyright © 2010 SuZhou Yacoo Science Co., Ltd All Rights Reserved Powered by: Founder International
Yacoo Information Management Platform 用户登录站内地图